Seguir
Gabriel Reina PharmD PhD
Gabriel Reina PharmD PhD
Clinica Universidad de Navarra (Microbiology)
Dirección de correo verificada de unav.es
Título
Citado por
Citado por
Año
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled …
C Chaccour, A Casellas, A Blanco-Di Matteo, I Pineda, ...
EClinicalMedicine 32, 2021
2302021
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12
J Castilla, I Martínez-Baz, V Martínez-Artola, G Reina, F Pozo, MG Cenoz, ...
Eurosurveillance 18 (5), 20388, 2013
1482013
Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A, and G against SARS-CoV-2 antigens
C Dobaño, M Vidal, R Santano, A Jiménez, J Chi, D Barrios, G Ruiz-Olalla, ...
Journal of clinical microbiology 59 (2), 10.1128/jcm. 01731-20, 2021
892021
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
C Dobaño, R Santano, A Jiménez, M Vidal, J Chi, NR Melero, M Popovic, ...
Translational Research 232, 60-74, 2021
882021
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ...
Journal of Clinical Virology 81, 82-89, 2016
862016
Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe
A Rivero-Juarez, M Frias, AB Perez, JA Pineda, G Reina, ...
Journal of hepatology 77 (2), 326-331, 2022
712022
Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000‐2015 period (the GEHEP 005 study)
A Aguilera, D Navarro, F Rodríguez‐Frias, I Viciana, AM Martínez‐Sapiña, ...
Journal of viral hepatitis 24 (9), 725-732, 2017
452017
Using NS5B sequencing for hepatitis C virus genotyping reveals discordances with commercial platforms
N Chueca, I Rivadulla, R Lovatti, G Reina, A Blanco, ...
PLoS One 11 (4), e0153754, 2016
452016
Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons
J Castilla, A Navascués, M Fernández-Alonso, G Reina, F Pozo, I Casado, ...
Vaccine 34 (11), 1350-1357, 2016
442016
Effectiveness of trivalent seasonal and monovalent influenza A (H1N1) 2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis
J Castilla, J Moran, V Martinez-Artola, G Reina, I Martinez-Baz, ...
Eurosurveillance 16 (7), 2011
432011
Effectiveness of the monovalent influenza A (H1N1) 2009 vaccine in Navarre, Spain, 2009–2010: cohort and case-control study
J Castilla, J Morán, V Martínez-Artola, M Fernández-Alonso, M Guevara, ...
Vaccine 29 (35), 5919-5924, 2011
412011
Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-β2-glycoprotein …
L La Rosa, G Covini, C Galperin, L Catelli, N Del Papa, G Reina, ...
Clinical & Experimental Immunology 112 (1), 144-151, 1998
401998
Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study
I Martínez-Baz, V Martínez-Artola, G Reina, M Guevara, MG Cenoz, ...
BMC Public Health 13, 1-8, 2013
382013
Isolation of Mycoplasma hominis from extragenital cultures
C Miranda, E Camacho, G Reina, J Turino, J Rodríguez-Granger, R Yeste, ...
European Journal of Clinical Microbiology and Infectious Diseases 24, 334-337, 2005
362005
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in …
C Chaccour, P Ruiz-Castillo, MA Richardson, G Moncunill, A Casellas, ...
Trials 21, 1-4, 2020
302020
Neutrophil extracellular traps, local IL-8 expression, and cytotoxic T-lymphocyte response in the lungs of patients with fatal COVID-19
I Melero, M Villalba-Esparza, B Recalde-Zamacona, D Jiménez-Sánchez, ...
Chest 162 (5), 1006-1016, 2022
282022
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis
J Castilla, I Martinez-Baz, A Navascués, M Fernandez-Alonso, G Reina, ...
Eurosurveillance 19 (6), 20700, 2014
282014
HTLV-1 infection in solid organ transplant donors and recipients in Spain
C de Mendoza, L Roc, R Benito, G Reina, JM Ramos, C Gómez, ...
BMC Infectious Diseases 19, 1-5, 2019
272019
Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination …
J Castilla, I Martínez-Baz, V Martínez-Artola, G Reina, F Pozo, ...
Euro Surveill 18 (5), 20388, 2013
272013
Enterovirus 75 and aseptic meningitis, Spain, 2005
A Avellón, G Rubio, G Palacios, I Casas, N Rabella, G Reina, C Pérez, ...
Emerging Infectious Diseases 12 (10), 1609, 2006
272006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20